Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/07/2025 ,inter alia, to consider and approve various agenda items
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Ltd has informed BSE that a meeting of its Board of Directors is scheduled to be held on July 3, 2025. The agenda, as stated in the intimation, is to consider and approve various items, though the specific nature of these items has not been disclosed. This is a standard pre-board-meeting intimation required under SEBI's Listing Obligations and Disclosure Requirements (LODR) regulations. Investors will need to wait for the post-meeting outcome to learn what was approved.
No direct impact on shareholders or stock price can be assessed yet, as the specific agenda items have not been disclosed. Investors should watch for the company's next filing after the meeting for details on what was approved, which could include results, dividends, or other corporate actions.